Mostim is the Generic version of Mozobil™ (PLERIXAFOR)

On December 15, 2008, the U. S. Food and Drug Administration (FDA) approved plerixafor, solution for subcutaneous injection, (Mozobil™, Genzyme Corp.) for use in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin lymphoma (NHL) and multiple myeloma (MM).

Peripheral blood stem cell mobilization, which is important as a source of hematopoietic stem cells for transplantation, is usually performed using granulocyte colony-stimulating factor (G-CSF), but is ineffective in around 15 to 20% of patients. Combination of G-CSF with Mostim (Plerixafor)   increases the percentage of persons that respond to the therapy and produce enough stem cells for transplantation


Mostim (Plerixafor)

Plerixafor Injection 24mg/1.2ml 
PACK :Single Injection

Dosing and Administration

The recommended dose of Mostim (Plerixafor) is 0.24 mg/kg body weight by subcutaneous (SC) injection. Use the patient’s actual body weight to calculate the volume of Mostim(Plerixafor) to be administered. Each vial delivers 1.2 mL of 20 mg/mL solution, and the volume to be administered to patients should be calculated from the following equation:

0.012 x patient’s actual body weight (in kg) = volume to be administered (in mL)

Based on increasing exposure with increasing body weight, the Mostim (Plerixafor) dose should not exceed 40 mg/day.


Administer Mostim(Plerixafor) approximately 11 hours earlier to initiation of each apheresis session for up to 4 successive days. Anaphylactic shock and serious hypersensitivity reactions, some of which have been life-threatening, have occurred in patients receiving Mostim (Plerixafor) Observe patients for signs and symptoms of hypersensitivity during and after Mostim (Plerixafor) administration for at least 30 minutes and until clinically stable. Only administer Mostim (Plerixafor) when personnel and therapies are immediately available for the treatment of anaphylaxis and other hypersensitivity reactions.

Recommended Concomitant Medications :

Administer daily morning doses of G-CSF (10 micrograms/kg) for 4 days prior to the first evening dose of  Mostim(Plerixafor)  and on each day prior to apheresis.

What are the possible side effects of Mostim (Plerixafor) ?

Get emergency medical help if you have any of these signs of an allergic reaction:
hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Tell your Doctor at once if you have a serious side effect such as:

  • easy bruising or bleeding, unusual weakness;
  • feeling like you might pass out; or
  • Pain in your upper stomach, spreading to your shoulder or back.

Less serious side effects may include:

  • nausea, vomiting;
  • diarrhoea, constipation;
  • dry mouth, numbness in or around your mouth

For more information on Mozobil™ (PLERIXAFOR) prescribing information please click here

Price of Mostim `in India , Cost of Plerixafor in India

Please contact +91 8652561080 for cost of Celrixafor in India
We assurance of quality and distribution anywhere in the world as per the buyer’s requirements.

Buy Mostim Online ?

We are not online Pharmacy, Mostim is a prescription medication pharmaceutical drug that legally requires a medical prescription to be dispensed.
Please contact us for more Details, On How To Buy this Celrixafor on Valid Prescription and On availability in India (Delhi, Mumbai, Chennai, Kolkata, Bangalore, Hyderabad, Ahmedabad, Pune, Nagpur, Patna etc.)

Mostim can be made available Delhi, Mumbai, Chennai, Kolkata, Bangalore, Hyderabad, Ahmedabad, Pune ,Nagpur ,Patna and other cities in India”

Send your Enquiry or Call +91 8652561080

Cost of Mostimin Belgium, Canada, China, Costa Rica, Dominican Republic Ethiopia, Fiji, France, French Polynesia, Germany, Guatemala, Iraq, Italy, Japan Jordan, Kenya, Lebanon, Morocco, Netherlands, New Caledonia, New Zealand, Oman, Papua New Guinea, Peru, Qatar, Russia, Spain, Switzerland, Tanzania, Tunisia, UK, USA

Please Note:

The above information is only for Medical profession only, please don’t try to self-medicate any of the medicine information Provided in this site, as all Medicine have life-threatening side-effect if not taken under proper medical guidance.  

Mostim (Plerixafor) is to be taken strictly under Medical  Supervision Only